← feed

Is NCT03431077 results overdue?

Yes — results are overdue. Primary completion was 2018-04-14; the FDAAA-801 reporting deadline (2019-04-14) passed 2671 days ago and no results are posted on ClinicalTrials.gov.

A Study of LJPC-501 in Pediatric Patients With Hypotension

NCT IDNCT03431077 ↗
SponsorLa Jolla Pharmaceutical Company (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2018-04-14 (ACTUAL)
Reporting deadline2019-04-14 (completion + 365d)
Days overdue2671
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 8b62154cfdab5ea2… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03431077. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →